Compare ARQT & AKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ARQT | AKR |
|---|---|---|
| Founded | 2016 | 1993 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 2.7B |
| IPO Year | 2020 | 1996 |
| Metric | ARQT | AKR |
|---|---|---|
| Price | $23.32 | $21.53 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 4 |
| Target Price | ★ $34.00 | $22.25 |
| AVG Volume (30 Days) | 905.0K | ★ 1.0M |
| Earning Date | 05-06-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 3.69% |
| EPS Growth | ★ 88.79 | N/A |
| EPS | N/A | ★ 0.22 |
| Revenue | $376,072,000.00 | ★ $410,757,000.00 |
| Revenue This Year | $34.85 | $3.21 |
| Revenue Next Year | $29.39 | $12.17 |
| P/E Ratio | ★ N/A | $98.18 |
| Revenue Growth | ★ 91.34 | 14.20 |
| 52 Week Low | $12.42 | $18.04 |
| 52 Week High | $31.77 | $22.36 |
| Indicator | ARQT | AKR |
|---|---|---|
| Relative Strength Index (RSI) | 48.06 | 62.93 |
| Support Level | $22.56 | $19.37 |
| Resistance Level | $23.46 | $21.76 |
| Average True Range (ATR) | 0.94 | 0.42 |
| MACD | -0.07 | 0.06 |
| Stochastic Oscillator | 36.38 | 68.20 |
Arcutis Biotherapeutics Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing treatments for dermatological diseases with high unmet medical needs. Its current portfolio is comprised of differentiated topical and systemic treatments with potential to treat immune-mediated dermatological diseases and conditions. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population. The Company has one reportable segment relating to the development and commercialization of treatments for dermatological diseases.
Acadia Realty Trust is a real estate investment trust that specializes in the operation, management, leasing, renovation, and acquisition of shopping centers and mixed-use properties with retail components. The company operates through three segments: REIT Portfolio segment consists of high-quality retail properties located in high-barrier-to-entry, densely-populated metropolitan areas with a long-term investment horizon; Investment Management segment holds the retail real estate in which the company co-invests with high-quality institutional investors; and Structured Financing segment consists of earnings and expenses related to notes and mortgages receivable Fees earned by the company as the general partner or managing member through Investment Management.